Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Blinken: Two-State Solution is the Only Way

Secretary of State Antony Blinken declared that the two-state…
Read more

Oregon First State to Require Vaccination Proof

Oregon is paving the way in requiring people to show their…
Read more

Antisemitic Attacks in UK Increase by 500%

Antisemitic attacks in the UK have increased by 500%. Breitbart…
Read more